Into 2030: What Adjustments Has the Global Pandemic Made to the Government Program for the Next Decade?

  • Outcomes of the Pharma-2020 program: challenges and results
  • Program “Pharma-2030”: priorities, main directions, challenges, and concerns
  • Manufacturing of pharmaceutical substances: how to reduce dependence on supplies from Asia?
  • Priorities in the development of innovative drugs and generics production
  • Cooperation with international companies in the framework of the localisation of drug production projects
  • Export potential of the Russian pharmaceutical industry: drug groups and markets

 

Dmitry Kudlay

Irina Novikova

Stanislav Naumov

Aleksander Semenov

Hourly Schedule

Wednesday, 28 April

10:00 - 11:00
Into 2030: What Adjustments Has the Global Pandemic Made to the Government Program for the Next Decade?

Date

28 Apr 2021
Expired!

Time

Moscow time
09:30 - 10:30
Online Platform

Location

Online Platform

Organizer

Advantix Pharma
Phone
+442080892886
Email
pharma@advantix.co.uk
Website
https://pharma.advantix.online/en/